Clinical Trial Update: IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Pediatric High-grade Glioma (HGG) [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating IL-8 receptor-modified CD70 CAR T cells in CD70-positive pediatric high-grade glioma; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-grade Glioma

Drugs mentioned

• IL-8 receptor-modified CD70 CAR T cells

Snippet

Sponsor: University of Florida | Conditions: High-grade Glioma | Phase 1 | Status: ACTIVE_NOT_RECRUITING